Lista de obras - Ellen Kapiteijn - Dominio Público Uruguay

(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges

artículo científico publicado en 2016

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

artículo científico publicado en 2022

A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients.

artículo científico publicado en 2016

A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature

artículo científico publicado en 2020

Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial

artículo científico publicado en 2012

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

article published in 2014

Adjuvant treatment of in-transit melanoma: Addressing the knowledge gap left by clinical trials.

scientific article published in 2022

Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response

artículo científico publicado en 2020

Anaplastic Thyroid Carcinoma; a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades

artículo científico publicado en 2020

Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

artículo científico publicado en 2014

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands

artículo científico publicado en 2016

Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program

artículo científico publicado en 2019

Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry

scientific article published on 27 January 2020

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial

artículo científico publicado en 2015

Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.

artículo científico publicado en 2009

Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands.

artículo científico publicado en 2016

Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data

artículo científico publicado en 2020

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer

artículo científico publicado en 2019

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline mutations

artículo científico publicado en 2018

Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma

artículo científico publicado en 2019

Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.

artículo científico publicado en 2017

Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial

scientific article published on 01 February 2017

Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer.

artículo científico publicado en 2016

Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations

scientific article published on 21 June 2019

Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands.

artículo científico publicado en 2017

Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

artículo científico publicado en 2012

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071

artículo científico publicado en 2020

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs

artículo científico publicado en 2020

Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper

article by Esther Bastiaannet et al published 16 July 2018 in Journal of Geriatric Oncology

Intermittent versus continuous systemic therapy as treatment for unresectable metastatic colorectal cancer

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).

artículo científico publicado en 2013

Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.

artículo científico publicado en 2016

Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature.

artículo científico publicado en 2017

Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients.

artículo científico publicado en 2016

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study

scientific article published on 01 March 2020

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease

artículo científico publicado en 2020

Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control

artículo científico publicado en 2002

Malignant pheochromocytoma and paraganglioma: management options

artículo científico publicado en 2020

Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors

scientific article published on 18 June 2020

Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy

artículo científico publicado en 2020

Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry

artículo científico publicado en 2019

Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status

artículo científico publicado en 2020

Neoantigen landscape dynamics during human melanoma-T cell interactions

artículo científico publicado en 2016

New treatment modalities in advanced thyroid cancer ⬇️

artículo científico publicado el 6 de abril de 2011

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.

artículo científico publicado en 2016

Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study

artículo científico publicado en 2020

Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies

artículo científico publicado en 2015

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial

artículo científico publicado en 2020

Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)

artículo científico publicado en 2020

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases

artículo científico publicado en 2021

Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study

artículo científico publicado en 2014

Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan

artículo científico publicado en 2017

Quality of Life After Curative Resection for Rectal Cancer in Patients Treated With Adjuvant Chemotherapy Compared With Observation: Results of the Randomized Phase III SCRIPT Trial

artículo científico publicado en 2019

Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.

artículo científico publicado en 2015

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

artículo científico publicado en 2018

Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.

artículo científico publicado en 2018

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

scientific article published on 01 February 2019

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial

scientific article published on 14 February 2019

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).

artículo científico publicado en 2018

Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma

artículo científico publicado en 2015

Severe colitis while responding to ipilimumab in metastatic melanoma

artículo científico publicado en 2012

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial

artículo científico publicado en 2013

So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020

scientific article published on 22 July 2019

Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination

artículo científico publicado en 2010

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

artículo científico publicado en 2011

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy

scientific article published on 07 May 2020

Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer

scientific article published on 21 November 2018

Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

scientific article published on 04 December 2019

Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma

artículo científico publicado en 2019

Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer

artículo científico publicado en 2019

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

scientific article published on 30 September 2019

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review

artículo científico publicado en 2019

Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis.

artículo científico

Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.

artículo científico publicado en 2012

To treat or not to treat: developments in the field of advanced differentiated thyroid cancer.

artículo científico publicado en 2014

Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway

artículo científico publicado en 2020

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

artículo científico publicado en 2022

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

artículo científico publicado en 2019

Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types

scientific article published on 19 June 2019

Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes

artículo científico publicado en 2018

[Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry]

scientific article published on 15 June 2018

p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.

artículo científico publicado en 2002

Lista de obras de Ellen Kapiteijn

(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients.

A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature

Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

Adjuvant treatment of in-transit melanoma: Addressing the knowledge gap left by clinical trials.

Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response

Anaplastic Thyroid Carcinoma; a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades

Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands

Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program

Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry

Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial

Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.

Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands.

Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline mutations

Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma

Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan.

Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial

Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer.

Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations

Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands.

Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs

Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper

Intermittent versus continuous systemic therapy as treatment for unresectable metastatic colorectal cancer

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).

Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.

Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature.

Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients.

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease

Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control

Malignant pheochromocytoma and paraganglioma: management options

Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors

Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy

Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry

Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status

Neoantigen landscape dynamics during human melanoma-T cell interactions

New treatment modalities in advanced thyroid cancer ⬇️

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.

Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study

Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial

Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)

Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases

Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study

Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan

Quality of Life After Curative Resection for Rectal Cancer in Patients Treated With Adjuvant Chemotherapy Compared With Observation: Results of the Randomized Phase III SCRIPT Trial

Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).

Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma

Severe colitis while responding to ipilimumab in metastatic melanoma

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial

So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020

Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy

Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer

Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma

Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review

Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis.

Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.

To treat or not to treat: developments in the field of advanced differentiated thyroid cancer.

Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma